
    
      A randomized, open-label, single dose, two-way crossover clinical trial to compare the
      safety, pharmacokinetic profiles of UI15AML055MT and AmosartanÂ® tablet 5/50 mg after a single
      oral administration in healthy male volunteers
    
  